Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (488)	7/8/1998 8:06:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 1722

State Looks At Necessity Of Viagra Minnesota To Decide If Impotence Drug Is Medically Needed Before Including In Medicare Program channel4000.com

To: Anthony Wong who wrote (488)	7/8/1998 8:09:00 PM
From: Anthony Wong	Respond to of 1722

J&J Adds Alcohol Warning to Motrin Label, Changes Tylenol Label Bloomberg News July 8, 1998, 6:25 a.m. PT J&J Adds Alcohol Warning to Motrin Label, Changes Tylenol Label New Brunswick, New Jersey, July 8 (Bloomberg) -- Johnson & Johnson said it will add a warning about alcohol use to the label for its painkiller Motrin and modify the painkiller Tylenol's label, which already warns about complications with alcohol use. The changes in the labels meet recent proposals from the U.S. Food and Drug Administration, said Johnson & Johnson, the world's fifth-biggest drugmaker, according to IMS Health Inc. The Motrin label will advise people who drink three or more alcoholic beverages a day to check with doctors about taking Motrin or other pain relievers. The drugs may increase risk of stomach bleeding. The Tylenol label, which already warns about alcohol use, will add that chronic heavy alcohol users may risk liver damage by exceeding the recommended dose of Tylenol. ''Generally, the alcohol warning on these products is targeted to the heavy user of alcohol,'' said Richard Dart, director at Denver's Rocky Mountain Poison and Drug Center. ''Occasional moderate drinkers who follow directions for appropriate dosing can be reassured that they can continue to use acetaminophen products, such as Tylenol, with confidence.'' Dart's comments were included in a release issued by Johnson & Johnson's McNeil unit, which sells consumer products. Johnson & Johnson rose 2 3/16 yesterday to 74 9/16. In November, the FDA said it planned to require the makers of all over-the-counter pain killers to add an alcohol warning to their labels. Johnson & Johnson, which already placed a voluntary warning on Tylenol, could benefit from the FDA proposal, which would put competitors that do not now have warning labels on their products on equal footing. Tylenol currently carries a warning similar to the FDA's proposed label, warning people who consume three or more alcoholic beverages daily to consult a doctor before using any pain medication. New Brunswick, New Jersey-based Johnson & Johnson, maker of Band-Aids, also sells the anemia drug Procrit and the schizophrenia drug Risperdal. --Kerry Dooley in the Princeton newsroom (609) 279-4016/dd